Focusing on seronegative RA, this review considers these concepts and their implications for the management of patients with this challenging, though sometimes overlooked, condition. PubMed, Best Pract Res Clin Rheumatol, 2014 Aug;28(4):651-659. (Also see: Antibodies of Rheumatoid Arthritis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.